Shahar Alon

3.7k citations
14 papers · 1.0k indexed · h-index 11
Topics
Single-cell and spatial transcriptomics (4 papers)RNA regulation and disease (4 papers)MicroRNA in disease regulation (3 papers)
Partner nations
IsraelUnited StatesItaly

In The Last Decade

Shahar Alon

14 papers receiving 1.0k citations

Peers

Shahar Alon
Comparison fields: 5 of 102
  • Molecular Biology 755
  • Cancer Research 180
  • Biophysics 154
  • Radiology, Nuclear Medicine and Imaging 75
  • Biomedical Engineering 71
Replace Sylvain W. Lapan with:
Sylvain W. Lapan United States
Galina V. Ermakova Russia
Eric Lubeck United States
Réza Shahidi Germany
Boris Joffe Germany
Xavier Heiligenstein France
Jorge Azpurua United States
Alex S. Shcheglov Russia
Chi‐Kuo Hu United States
Amy Shaub Maddox United States
Shahar Alon relative to Sylvain W. Lapan United States Sylvain W. Lapan's profile →
Citations per field
00.5×1.5×
Sylvain W. Lapan · 1×
Citations per year

Countries citing papers authored by Shahar Alon

Since Specialization
Citations

This map shows the geographic impact of Shahar Alon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shahar Alon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shahar Alon more than expected).

Fields of papers citing papers by Shahar Alon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shahar Alon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shahar Alon. The network helps show where Shahar Alon may publish in the future.

Co-authorship network of co-authors of Shahar Alon

This figure shows the co-authorship network connecting the top 25 collaborators of Shahar Alon. A scholar is included among the top collaborators of Shahar Alon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shahar Alon. Shahar Alon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
#WorkIndexed citations
1 1
2 1
3 22
4 2
5 13
6 20
7 222
8 103
9 268
10 47
11 19
12 145
13 88
14 89

About Shahar Alon

Shahar Alon is a scholar working on Structural Biology, Biophysics and Cancer Research, having authored 14 papers that have together received 1.0k indexed citations. Recurring topics across this work include Single-cell and spatial transcriptomics (4 papers), RNA regulation and disease (4 papers) and MicroRNA in disease regulation (3 papers). The work is most often cited by research in Structural Biology (55 citations), Biophysics (154 citations) and Cancer Research (180 citations). Shahar Alon has collaborated with scholars based in Israel, United States and Italy. Frequent co-authors include Eli Eisenberg, George M. Church, Franco Locatelli, Yanay Ofran, Edward S. Boyden, François Vigneault, Angela Gallo, Inbal Sela‐Culang, Shoh Asano and Noa Liscovitch‐Brauer. Their work appears in journals such as Cell, Nucleic Acids Research and Bioinformatics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026